Comparison of efficacy from phase 3 clinical trials of IPX066, an extended-release carbidopa-levodopa formulation, in parkinson's disease

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: 4327870566b161f41ed1cdecfeca4bff632f954d
First added on: Feb 07, 2025